Additionally, an analysis of the regulatory mechanisms that contribute to cancer development has revealed that subclonal mutations of AHNAK and AHNAK2 in GBM can impact crucial molecules and processes linked to glioma progression [27]. This evidence concerns the gene AHNAK2 and cancer.